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Abstract The WW domain is a structured protein module found 
in a wide range of regulatory, cytoskeletal, and signaling 
molecules. Its ligands contain proline-rich sequences, some of 
which show a core consensus of XPPXY that is critical for 
binding. In order to gain a better understanding of the molecular 
and biological functions of WW domains, we decided to predict 
their cognate ligands by searching databases for proteins 
containing the XPPXY consensus. Using several axioms that 
take into account evolutionary conservation and functional 
similarity, we have identified four groups of proteins representing 
candidate ligands that signal through known or unknown WW 
domains. These include viral Gag proteins, sodium channels, 
interleukin receptors, and a subgroup of serine/threonine kinases. 
In addition, we proposed that dystrophin and I~-dystroglycan bind 
through the WW-XPPXY link and that interference with this 
interaction could result in muscular dystrophy. Our study 
provides guidelines for experiments to probe the molecular and 
biological functions of the WW domain-ligand connection. 
Should these predictions be proven empirically, the results may 
have important ramifications for basic research and medicine. 
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1. Background and rationale 
The WW domain is a protein module found in a wide range 
of structural, regulatory, and signaling molecules [1]. It has 
been found in 20 different proteins [2,3] including dystrophin; 
YAP, an adaptor-like protein that interacts with the SH3 
domain of the Src-family protein tyrosine kinase Yes; 
ORF1, a human protein containing a Ras GTPase activating 
domain; Essl, a yeast protein essential for cell division; Rsp5, 
a yeast protein that is involved indirectly in regulation of 
transcription; FE65, a brain-specific adaptor protein; proteins 
that bind to formins - the latter is a group of gene products 
encoded by the mouse limb deformity locus; and several other 
proteins from human, rat, yeast, nematode, and tobacco 
[2,4,5]. 
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The domain was identified as a result of our search for 
substrates and regulators of the Yes proto-oncogene product. 
Yes is a non-receptor protein tyrosine kinase of the Src fam- 
ily. It is expressed at elevated levels in cerebellar Purkinje cells 
and in lung, kidney, and intestinal epithelial cells; this pattern 
of expression suggests that Yes could be involved in secretion 
and regulation of ion transport [6]. Based on results of Hirai 
and Varmus [7], we reasoned that by identifying molecules 
that interact with Yes in vivo, we should be able to character- 
ize the mode of action of the Yes protein in normal and viral- 
Yes transformed cells. YAP (Yes-associated protein) was iso- 
lated as one of the proteins that binds the SH3 (Src homology 
3) domain of Yes; its sequence contains an SH3-binding motif 
with the core consensus PXXP (P, proline; X, any amino acid, 
not necessarily the same) reported by Schreiber and colleagues 
[8-12]. YAP is phosphorylated in vivo by an unknown serine 
kinase, indicating that it may form a novel link between the 
serine/threonine and tyrosine signaling pathways [8]. Initial 
evidence for the WW domain came from comparison of the 
sequences of human, mouse, and chicken YAP. This compar- 
ison revealed that the mouse protein contains an insert not 
found in the human and chicken proteins, with significant 
similarity to a sequence upstream in all three proteins. Com- 
puter-aided analysis of this sequence, together with the results 
of biochemical and structural studies suggested that this re- 
gion represented a new protein domain. One of the distin- 
guishing features of the domain is the presence of two highly 
conserved tryptophan residues (W), hence the name: the WW 
domain [1]. Its length was set at 38 amino acids, the length of 
the mouse insert [2]. 
Since we proposed that the WW domain of YAP might 
mediate protein-protein interaction [1,2], we performed a 
functional screen of a cDNA expression library to identify 
its ligand. Two putative binding proteins were isolated and 
named WBP-1 and WBP-2 [13]. Sequence comparison of the 
two ligands revealed that they share a proline-rich region that 
binds strongly and specifically to the WW domain of YAP. 
The region consists of a five-amino acid sequence, PPPPY (the 
PY motif), which is perfectly conserved between WBP-1 and 
WBP-2 and occurs three times in WBP-2 [13]. By sequentially 
replacing each of these five positions with alanine for in vitro 
binding assays, a preliminary consensus of XPPXY (P, pro- 
line; Y, tyrosine; X, any amino acid, not necessarily the same) 
was established as necessary for binding [13]. This consensus 
is distinct from the SH3-binding motif PXXPo Consistent with 
this observation, WBP-1 does not bind to the arbitrarily cho- 
sen SH3 domains of Yes, Fyn, Abl, and GAP [13]. Consider- 
ing that the XPPXY motif shows a significant level of speci- 
ficity in binding to at least a subset of WW domains, and 
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knowing that as a proline-rich sequence it must bind rapidly 
and tightly [14], we think that XPPXY may represent an im- 
portant signaling site utilized by many proteins. 
Since a consensus of XPPXY is critical for binding to the 
WW domain of YAP, we propose that ligands to other WW 
domains can be predicted by searching databases for proteins 
containing the consensus. However, there are several prob- 
lems inherent in this simple proposal: First, the motif is so 
small that the chance of its random occurrence in a sequence 
database is high. In fact, the number of occurrences of the 
motif found in the search is similar to that expected to appear 
at random. Therefore, many of the protein sequences retrieved 
will probably be insignificant because the presence of the mo- 
tif in these proteins will have been the result of coincidence, 
not of evolutionary conservation. Some of the XPPXY motifs 
could be embedded in the proteins and may not be able to 
play the role of a surface-exposed module mediating protein- 
protein interaction. Second, the core consensus established for 
binding to the WW domain of YAP, with the 'alanine scan,' 
may only cover selected subsets of known WWs - perhaps 
those most closely related to the WW domain of YAP. Other 
variants of the consensus (XPPX [any aromatic residue] or 
XPPXXY) are conceivable (Sudol and Bougeret, unpublished 
results from phage display library screens). Indeed, polypro- 
line regions lacking tyrosines, have recently been found in 
formin isoforms to bind to WW domain-containing proteins 
in vitro [4] (Fig. 5C). The consensus i also limiting because it
does not take into account he contribution of flanking amino 
acids that may dictate or modulate the ligand-ligate interac- 
tion [15-17]. 
In order to determine which of the proteins retrieved con- 
tain the consensus as a result of evolutionary pressure, and to 
therefore determine which of the proteins are likely to interact 
with WW domain family proteins, we have looked for pat- 
terns in the primary structure and function of the proteins 
retrieved. The XPPXY motifs in proteins with conserved pat- 
terns are likely to mediate interaction i  vivo with WW family 
proteins. Of course, these XPPXY-containing proteins may 
interact with not-yet-isolated WWs, and could be used as 
functional probes to retrieve new members of the WW family 
[3]. In addition to patterns in the topological conservation of 
the XPPXY motif, we have looked for possible correlations in
function between proteins containing the motif and proteins 
containing the WW domain, again as indications of interac- 
tions that occur in vivo. Guided by these two axioms we have 
identified a series of putative WW ligand proteins, providing 
suggestions for experiments o demonstrate cognate interac- 
tions between XPPXY motif-containing and WW domain- 
containing proteins and to probe the biological aspects of 
this molecular link. 
2. Methods 
The Fasta program [18] was used to search the Translated 
Genbank database of protein sequences for the motif 
XPPXY. To facilitate the searches, 20 separate screens were 
performed, each with a different amino acid in the first posi- 
tion of the motif. A total of 4410 occurrences of the motif 
were found in the 127887 sequences, containing a total of 
39288428 residues, of the Genbank as of August, 1995. The 
actual number of proteins containing the motif is smaller since 
several proteins contained the motif in multiple copies. Never- 
theless, considering that one would expect o find on the order 
of 4900 occurrences of the motif if the composition of the 
Genbank proteins were completely random, most of the pro- 
teins retrieved probably contain the motif as a result of 
chance. In order to begin to identify the proteins in which 
the motif may have a distinct, WW-related function, we se- 
lected 185 occurrences of the motif to study further (once 
again, the actual number of proteins containing these occur- 
rences of the motif is smaller). This selection was made based 
upon the descriptions of the proteins - those selected seemed 
to be the best candidates for involvement in intracellular sig- 
naling. From the 185 occurrences of the motif, proteins were 
grouped together based upon similarity of function, interac- 
tion with similar molecules, localization to similar parts of the 
cell, and expression in similar organs. Many proteins were 
included in more than one group. Within each group the 
lengths of the protein sequences, the positions of the XPPXY 
motifs within their sequences, the exact sequences of the mo- 
tifs, and relative homology of the entire proteins were com- 
pared. In addition, database searches with the Blastp program 
[19] were used to establish ow these sub-groups related to 
any larger groups of proteins. For the groups of proteins in 
question, the most significant findings are: viral-Gag proteins, 
sodium channels, interleukin receptors, and serine/threonine 
kinases. In addition, we report the identification of the motif 
in dystroglycan and propose the interaction of this motif with 
the WW domain of dystrophin. 
3. Protein families with proline motifs 
3.1. Gag proteins 
Gag proteins of retroviruses play a key role in the genesis 
and assembly of viral particles [20]. Because of their frequent 
fusion to cellularly derived sequences in viral oncogene prod- 
ucts, Gag proteins are compelling candidates for involvement 
in signaling processes [21]. In fact, numerous studies have 
implicated Gag proteins as modulators of transforming po- 
tential for many oncogenic proteins (e.g. [22]). 
The XPPXY motif was found in 13 distinct Gag proteins. 
Eleven of these were from various mammalian and avian 
retroviruses, one was a mouse cellular homolog, and one an 
endogenous virus-derived Gag protein in fungus. Among the 
collection, several Gag proteins belonged to viral oncogenes, 
including Crk, Erb-A and -B, Fms, Fps, and Yes. Compar- 
ison of the 13 Gag proteins in the 25-residue region, arbitra- 
rily chosen, extending 10 residues on either side of the 
XPPXY motif revealed that several of them share significant 
homology. Excluding similar sequences from consideration, 
there are six distinct sequences surrounding the motif. Except 
for the perfect conservation of the XPPXY motif, no se- 
quences hare more than 15% identity in the 25-residue re- 
gion. Even though Gags are presumably related evolutiona- 
rily, several of the Gags containing the XPPXY motif show 
little sequence similarity to each other in this region. This 
makes unlikely the possibility that XPPXY is only conserved 
in Gags because it is a part of a larger, well conserved region. 
Of the six XPPXY motifs, those from Rous sarcoma virus 
(RSV) and Bovine leukemia virus (BLV) contain prolines in 
the first and fourth positions, identical to the PY motif in 
WBP-1 and WBP-2, and those from Friend murine leukemia 
virus (FMLV) and Human T-cell leukemia virus 1 (HTLV-1) 
contain prolines in the fourth position but not the first (Fig. 1). 
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Despite the abrupt divergence of the homology of these 
sequences before and after the XPPXY motif, the 13 proteins 
demonstrate surprising similarity in the relative position of the 
motif within their sequences. Of the 13 Gags, those from RSV 
and FMLS (as well as the homologous Gags from chicken 
provirus RAV-O, avian sarcoma virus, and wild mouse eco- 
tropic virus), contain the motif approx. 170 residues from the 
beginning of the protein; and those from HTLV-1, the Fusa- 
rium oxysporum endogenous virus, and BLV, (as well the 
homologous Gag from avian erythroblastosis virus), contain 
the motif between 80 and 120 residues from the beginning of 
the protein. Of the 13 proteins, only one of the Gag proteins 
from avian erythroblastosis virus neither contains the motif in 
one of the locations described above nor is homologous to a 
protein containing the motif in one of these locations (Fig. 1). 
A search using the Blastp program of the 25 residues ur- 
rounding the motif in RSV Gag against all available sequence 
databases revealed no significant homology to any Gags lack- 
ing the motif. According to this search, all reported members 
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Fig. 1. Structures and partial sequences of Gag proteins containing 
the XPPXY motif. Only non-homologous (less than or equal to 
15% identity in the 10 residues on either side of the motif) Gags are 
shown. The XPPXY motif is represented by the boxed PY. The full 
names of the viruses and accession umbers are as follows: RSV, 
Rous sarcoma virus [D10652] (homologous equences: chicken pro- 
virus RAV-O [M73497], avian erythroblastosis virus [M32090], avian 
sarcoma virus [J0207]); FMLV, Friend murine leukemia virus 
[Zl1128] (homologous equences: mouse p12 homologue (X72930), 
feline sarcoma virus [K01643], wild mouse ecotropic virus 
[M26528]; HTLV-1, human T-cell leukemia virus type 1 [D13784]/ 
human t-lymphotropic virus type 1 [$745562]; End. V, endogenous 
virus from the fungus Fusarium oxysporum [L34658]; BLV, bovine 
leukemia virus [M10987]; AEV, avian erythroblastosis virus 
[X52209]. 
of the subfamily of Gags similar to RSV contain the XPPXY 
motif. This finding is expected if the motif has functional 
significance in Gags. 
In support of our proposal, the PPPPY motif in the p2b 
region of RSV gene was shown to be required for a late step 
in budding after the Gag proteins have been targeted to the 
membrane [23]. This finding constitutes direct evidence of the 
biological function of the XPPXY motif. Which of the WW 
domain-containing proteins interacts with the PPPPY se- 
quence of Gag remains to be determined; YAP is a potential 
candidate (see also Fig. 5A). The role of the PPPPY motif 
may be related to proposed functions of motifs of the form 
PXY or PXXY in endocytosis. The motifs PPGY (a version 
of the XPPXY motif) in lysosomal acid phosphatase [24], 
NPXY in the LDL receptor [25], and NPLIY in the 132-ade- 
nergic receptor [26] have been shown to adopt reverse-turn 
conformations, essential as internalization signals. These sig- 
nals are proposed to interact with coated pit cytoplasmic re- 
ceptors [24] or adaptor proteins [25]. Although viral budding 
and protein internalization seem distinct, they are related pro- 
cesses in that they both involve localization to the membrane 
and result in its alteration. Perhaps the XPPXY motif in Gags 
and the [P/N]PXY motifs in lysosomal acid phosphatase and 
the LDL receptor convey signals similarly by interacting with 
membrane proteins containing WW or PTB/PID domains. 
Considering that the PPPPY motif is known to bind to the 
WW domain of YAP, we propose that in general these Gag 
proteins interact, through their XPPXY motifs, with a group 
of WW family proteins. This is consistent with the implication 
of Gag proteins in modulation of transformation, resulting 
from the physical fusion of several of the Gag proteins to 
viral oncogene products, including Yes. To illustrate our pro- 
posal we present here a model of interaction between viral Yes 
(or Crk) oncogene product and cellular YAP protein (Fig. 
5A). According to this 'double interaction' model, the WW 
domain of YAP binds to the PPPPY motif of Gag and pre- 
vents the normal signaling of YAP by interaction with WBP-1 
or WBP-2 proteins which when in free, unbound form, could 
be involved in positive control of cell growth. This simple, yet 
attractive model is being tested experimentally. 
3.2. Sodium channels 
Sodium channels are membrane-spanning proteins essential 
for regulating sodium ion concentrations in tissues as diverse 
as nervous tissue and kidney epithelium. The importance of 
their role in metabolism is illustrated by the Mendelian form 
of hypertension known also as Liddle's syndrome, which re- 
suits from mutations of the 13-subunit of the human epithelial 
sodium channel [27-29]. Liddle's syndrome is one of the many 
genetic traits that leads to severe hypertension, in this case 
through excessive reabsorption of sodium in the distal ne- 
phron of the kidney [27,28]. The control of ion passage by 
sodium channels, or the number of sodium channels present 
in the membrane, may be regulated by signals from intracel- 
lular proteins. 
Nine sodium channel proteins were found to contain the 
XPPXY motif. Of these nine, eight contained the motif be- 
tween 20 and 50 amino acids from the C-terminus. The only 
one that did not contain the motif in this location was from 
the jellyfish Cyanea capillata; therefore its discrepancy from 
the pattern found in the other channels, mostly vertebrate, can 
possibly be explained by its evolutionary distance from them. 
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As before, the 25 residues urrounding the motif were com- 
pared. Eliminating from consideration similar sequences, and 
counting twice the one protein that contained two copies of 
the motif, there are seven distinct sequences surrounding the 
motif (Fig. 2). Besides the motif, conserved in all of them, 
these sequences hare no more than 25% identity. Interest- 
ingly, however, there seems to be a general trend toward small 
hydrophobic or slightly polar residues preceding the motif and 
charged residues following it. Of the sodium channel XPPXY 
motifs, one of the two from the epithelial sodium channel c~- 
subunit contains four prolines, as in WBP-1 and WBP-2. This 
occurrence of the motif has been included for completeness; 
however, it may not be significant since it falls in the extra- 
cellular egion of the channel, a location at which signaling by 
the XPPXY motif is perhaps unlikely - so far there is no 
evidence for the presence of WW modules in extracellular 
compartments. The XPPXY motifs from the squid sodium 
channel, the 15- and 7-subunits of the epithelial sodium chan- 
nel, and the second motif from the ct-subunit contain proline 
in the first but not the fourth position (Fig. 2). A Blastp 
program search of the 25-residue segment of the epithelial 
sodium channel 13-subunit (arbitrarily chosen) against all 
available protein databases revealed that it does not contain 
significant similarity to any sodium channels lacking the 
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aENaClRat F PHPLQRLRT~PPPPY~SGRTARSGS S 
aENaC/Rat GMTPPLALTA]PPPAYIATLGPSAPPL 
BNaClII/Rat EKTDGSSSTT~SPPSY~DSVTKPDKEK 
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Fig. 2. Structures and partial sequences of sodium channel proteins 
containing the XPPXY motif. Only non-homologous (less than or 
equal to 25% identity in the 10 residues on either side of the motif) 
sodium channels are shown. The XPPXY motif is represented by 
the boxed PY (see explanation of ctENaC dotted box in text). The 
full names of the proteins and accession umbers, if available, are 
as follows: ~ENaC/human, human epithelial sodium channel B-sub- 
unit [53] (rat ortholog [53]); 7ENaC/human, human epithelial so- 
dium channel 7-subunit [X77933]; txENaC/human, human epithelial 
sodium channel o~-subunit [X70497] (homologous to human kidney 
amiloride-sensitive sodium channel [L29007]); BNaCIII/rat, rat brain 
sodium channel III [Y00766] (homologous to rat brain sodium 
channel I [X03638]); ctCNaC/rat, rat cardiac specific sodium channel 
ct-subunit [M27902]; NaC/squid, Loligo opalescens sodium channel 
[L19979]; NaC/jellyfish, Cyanea capillata sodium channel [L15445]. 
XPPXY motif (although it does show 36% homology to a 
potassium channel in which the motif is not perfectly con- 
served). 
The ~-, 15- and 7-subunits of the epithelial sodium channel 
in humans are involved in Liddle's syndrome, and the 
XPPXY motif of the 15-subunit has been directly implicated 
in the disease. In one patient, a de novo mutation causing the 
replacement of the third proline in the PPPNY motif with a 
leucine and led to Liddle's syndrome [30]. In another case, the 
replacement of the terminal tyrosine in the PPPNY motif 
with histidine also correlated with the clinical diagnosis of 
Liddle's syndrome [31]. Other mutations of the 15-subunit 
that have been reported to result in Liddle's syndrome all 
involve deleted portions of the intracellular C-terminal region, 
containing the PPPNY motif [28]. Replacement of the tyro- 
sine with an alanine leads to an increase in the current of the 
mutated channel expressed in frog oocyte system, at least as 
great as that in a Liddle's patient [32] The same result was 
obtained with the ct- and 7-subunits. Therefore, the XPPXY 
motif may perform a similar function in each subunit [32]. 
It seems likely from these findings that the level of sodium 
passage is regulated by the interaction of the XPPXY motif of 
the channel with a WW family protein (Fig. 5B). Such a 
protein has recently been identified as Nedd4, which contains 
three WW domains and can interact with the 15- and y-sub- 
units of the channel [33]. Therefore, Nedd4 (or a closely re- 
lated protein) may be a suppressor of channel activity [33]. In 
this case, mutation or absence of the XPPXY motif of the 
channel would prevent interaction with Nedd4, leading to in- 
creased channel current. Another possible explanation of 
XPPXY regulation of sodium passage is that the XPPXY 
motif/Nedd4 link controls the number of channels present in 
the membrane, either by regulating channel degradation [34], 
channel insertion, membrane localization, or channel intema- 
lization [32]. These data also support he proposal of a con- 
served function for the motif in the other sodium channels 
described above, which contain the motif in a similar relative 
position to the epithelial sodium channel subunits. Sodium 
conductance of these channels may be similarly controlled 
by WW family proteins. 
3.3. Interleukin receptors 
Interleukins are hormones that, through their interaction 
with interleukin receptors, regulate the growth and differentia- 
tion of B cells, T cells, and other cells of the immune system, 
and play a central role in the mammalian immune response 
[35-37]. The importance of the interleukin receptors is illu- 
strated by the X-linked disease severe combined immunodefi- 
ciency (SCID), which has been shown to result from muta- 
tions in the Y chain of the human and dog Interleukin-2 (IL-2) 
receptor [38-40]. Males affected by SCID suffer from severe 
opportunistic infections and die early in life if not treated 
through a bone marrow transplant [39]. Obviously essential 
to the function of the interleukin receptors are their intracel- 
lular regions, which must interact with cellular proteins in 
order to convey the signal of the interleukin hormone within 
the cell. 
Three of the interleukin receptors, in various mammals, 
were found to contain an XPPXY motif in their intracellular 
regions. These were the human, dog, and mouse IL-2 recep- 
tor 7 chain, implicated in SCID, the mouse and rat IL-6 
receptor, and the mouse IL-7 receptor (sequences of other 
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orthologs of these receptors were not available). Similar to 
the Gag proteins, the XPPXY motif is conserved among the 
three interleukin receptors while the surrounding 25 amino 
acids share no more than 15% identity. One of the proteins 
out of the six contains prolines in the first and fourth posi- 
tion, like WBP-1 and WBP-2, one contains a proline in only 
the first, and one contains a proline in only the fourth 
(Fig. 3). Also like the Gag proteins, the relative position of 
the motif is highly conserved among the interleukin receptors. 
The lengths of the three proteins are similar, with the IL-2 
receptor 7 chain approx. 370 residues long and the IL-6 and 
IL-7 receptors approx. 460 amino acids long. The XPPXY 
motif is around amino acid 360 in IL-2R, 400 in IL-6R, and 
400 in IL-7R. A Blastp search of the 25-residue segment of 
the IL-2 receptor 7 chain against all available protein se- 
quences revealed no significant homology to any other cyto- 
kine receptors; therefore the sub-group of interleukin recep- 
tors containing the motif does not seem to correspond to any 
larger group. 
One possibility is that the interleukin receptors relay the 
signal from the interleukin hormone through the XPPXY 
motif in their intracellular region to a cellular WW family 
protein. In the case of IL-2, it is tempting to speculate that 
a malfunction in this process results in SCID (Fig. 5D). Of the 
documented mutations that lead to SCID in humans, four are 
single-base pair substitutions or deletions that lead to prema- 
ture stop codons either in the extracellular region or the in- 
tracellular egion preceding the XPPXY motif [38,39]; in 
either case, the mutations lead to a protein lacking an XPPXY 
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PadialSequence 
SPCNQHSPYW~TLKPET* 
SPCSQHSPYWiAPPC¥1TLKPEETGALIP* 
SPCSLHSPYWIPPPCYISLKPEA* 
AEKESKTTSPIPPPPYISLGPLKPTFL 
AEKESKTT--ISPPP¥1PLGPLKPTFL 
SPDYRDGDRNIRP~WYIQDLLPNSGNT 
Fig. 3. Structures and partial sequences of interleukin recetor pro- 
teins containing the XPPXY motif. Only non-homologous (less than 
or equal to 15% identity in the 10 residues on either side of the mo- 
tif) sodium channels are shown. The XPPXY motif is represented 
by the boxed PY. Asterisks denote the ends of sequences. The full 
names of the proteins and accession umbers are as follows: IL-2R 
7/human, human interleukin-2 receptor 7-chain [Dl1086]; IL-2R 7/ 
dog, dog interleukin-2 receptor 7-chain [U04361]; IL-2R 7/mouse, 
mouse interleukin-2 receptor t~-chain [X75337]; IL-6R/mouse, mouse 
interleukin-6 receptor [)(53802]; IL-6R/rat, rat interleukin-6 receptor 
[M58587]; IL-7R/rat interleukin-7 receptor [M29697]. 
motif. Our suggestion of a role for XPPXY signaling in SCID 
would not be surprising, considering the recent implication of 
the Jak3 kinase in the SCID syndrome [41]. In normal cells, 
the Jak3 kinase interacts with the C-terminus of several inter- 
leukin receptor Y chains [41]. Perhaps a WW family protein 
may interact with the C-terminus of IL-2 Y chain in a manner 
similar to Jak3 or it may simply serve as an adaptor protein 
between the IL-2 receptor and a tyrosine kinase. 
3.4. Serinelthreonine kinases 
Since YAP is phosphorylated in vivo by an unknown serine 
kinase, serine/threonine kinases are of particular interest as 
candidates for involvement in WW domain XPPXY ligand 
signaling. It was therefore appealing to find the XPPXY motif 
in several serine/threonine kinases, suggesting structural, and 
possibly functional, significance. 
A total of 41 protein kinases were found to contain at least 
one copy of the XPPXY motif. No patterns that would in- 
dicate evolutionary conservation of the XPPXY motif have 
yet been identified in those described as tyrosine kinases, 
among which is the Abl proto-oncogene. Fourteen of the 
serine/threonine kinases, however, contain an XPPXY motif 
at a conserved position in their catalytic domains [42,43]. 
These serine kinases come from several organisms includ- 
ing human, Drosophila, entamoeba, and tobacco - and act 
on a variety of substrates. Of the 14, five are orthologs of 
MAP kinase-associated protein kinase, and two, from tobac- 
co and the ice plant, are highly similar. Therefore, there are 
nine distinct serine/threonine kinase sequences containing the 
motif. The presence of the motif in MAP kinase-associated 
protein kinase 2 (MAPKAP2) is interesting in itself. One of 
the WW family proteins is Msbl, a suppressor of mutations 
in the bckl gene encoding a MAP kinase kinase kinase, and a 
suppressor of mpkl (yeast Map kinase) mutations ([2], K. 
Matsumoto, personal communication). In fact, one could 
speculate that the ability of Msbl to suppress mpkl muta- 
tions is related to an interaction of its WW domain with the 
XPPXY motif of MAP kinase-associated protein kinase (Fig. 
5E). 
Unlike the previous entries which share relatively little 
homology to each other in the region directly surrounding 
the XPPXY, the serine/threonine kinases, as is expected 
from the presence of the motif in their catalytic domain, con- 
tain high homology and many conserved features in the re- 
gion immediately surrounding the motif. One possible indica- 
tion against he significance of the motif in serine/threonine 
kinases is that a Blastp search with the twenty five residue 
segment of MAPKAP2 showed significant homology to the 
catalytic domains of several kinases that lacked a perfect 
XPPXY motif. But this finding does not eliminate the possi- 
bility that the XPPXY has a specialized function within the 
catalytic domains of the kinases reported here. As is indicated 
in the consensus equence (Fig. 4), only six residues are con- 
served in all nine serine kinases, three of which are the con- 
served residues of the motif. The residue in the fourth position 
of the motif is either phenylalanine or tyrosine for the nine 
serine kinases. This is perhaps an indication that the fourth 
residue contributes to the specificity of the motif. It is inter- 
esting to note that this region, like the corresponding region in 
the sodium channel proteins, contains a prevalence of hydro- 
phobic or slightly polar residues preceding the motif and a 
prevalence of charged residues following the motif (Fig. 4). 
The motif is consistently ocated between 120 and 200 residues 
from the C-terminus of each protein, suggesting a relatively 
similar position for the XPPXY motif-containing region in the 
overall structure of the proteins. These theoretical data, as 
well as the potential involvement of two already characterized 
WW family proteins in the MAP kinase serine phosphoryla- 
tion pathway, suggests that WW family proteins could be 
either substrates for phosphorylation by these kinases, or 
adaptor molecules, of the same type as YAP. 
3.5. Dystrophin and I~-dystroglycan 
Our search of the protein sequence database with the 
XPPXY consensus identified the ~-dystroglycan receptor as 
a possible ligand of a WW domain. Since we have identified 
the WW domain in dystrophin, and it has been previously 
noted that the location of this domain in dystrophin is similar 
to that of the site at which dystrophin binds to dystroglycan 
[1,2], we decided to study this possble link further. 
I]-Dystroglycan was found to contain at least two XPPXY 
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Partial Sequence 
GVIMYI L LC G~-~--~ SNHGLAI S PG 
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GhhhYEMLhG - PPFY Dt th .... tK 
Fig. 4. Structures and partial sequences of serine/threonine kinase 
proteins containing the XPPXY motif. Orthologs are not shown. 
The XPPXY motif is represented by the boxed PY. In the consen- 
sus line, t indicates a predominately turn-like or polar position; h 
represents a predominantly h drophobic position. Bold residues in 
the consensus line are perfectly conserved in all 9 sequences and 
non-bold residues are conserved in 6-8 sequences. The full names of 
the proteins and accession umbers are as follows: MAPKAP2/hu- 
man, human MAP kinase activated protein kinase [X75346] (ortho- 
logs: rabbit [X75345], hamster [X82220], Drosophila [U20757]): 
PRKAGC/human, human testis-specific protein kinase 7-subunit 
[M34182]; CamKI/human, human calcium/calmodulin dependent 
protein kinaseI [L41816]; PKTL7/tobacco, tobacco PTKL7 protein 
kinase [X71057] (ortholog: ice plant [Z30329]); RCK2/yeast, yeast 
RCK2 protein kinase [X71065]; PTK1/Trichoderma, Trichoderma 
reesei QM9414 serine/threonine protein kinase [U05811]; YPK1/ 
yeast YPK1 protein kinase [M21307]; YKR2/yeast, yeast YKR2 
protein kinase [M24929]. 
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motifs: one is of the form PPPEY, the other SPPPY and the 
latter is located at the very carboxy-terminal end of the pro- 
tein [44]. Recent studies implicated the very carboxy-terminal 
sequence containing the SPPPY motif in mediating interaction 
with dystrophin; however, the precise region in dystrophin 
that binds the polyproline region was not delineated [45]. 
We propose that dystrophin and 13-dystroglycan bind through 
WW-XPPXY interaction and that interference with this inter- 
action (through deletion of the WW domain, for example) 
could result in muscular dystrophy (Fig. 5F). This must be 
tested experimentally in transgenic mice. 
3.6. Further considerations 
To look for further characteristics of the XPPXY motif in 
the proteins described, we have identified features of the first 
and fourth positions of the motif that may tend to expose it 
on the surface of a protein, and therefore allow it to interact 
with other proteins. One such feature is the presence of pro- 
lines in these positions, as is the case with WBP-1 and -2. 
Several studies have been conducted escribing eneral struc- 
tural features of proline residues and proline-rich motifs 
[14,46,47]. The relative rigidity of a string of four prolines is 
likely to force the motif to a protein's urface regardless of the 
surrounding sequence (G. Rose, personal communication). 
This is a good indication of the motifs functional significance 
in proteins such as Rous sarcoma virus Gag, as well as in 
proteins containing an additional proline in only the first or 
only the fourth position of the motif. 
Another feature of the motif that may force it to the protein 
surface is the presence of charged residues in the first or 
fourth positions. As has been previously reported, there is a 
direct correlation between residue hydrophobicity and the 
average area of the residue buried (not exposed to the protein 
surface) within reported proteins [48,49]. Occurrences of the 
motif are therefore more likely to be on the protein surface if 
they contain a charged or polar residue. The presence of ser- 
ine, asparagine, or arginine in the fourth position of the motif 
in six of the nine sodium channels indicates that the motif is 
more likely to be exposed on the surface of these proteins 
([47], and B. Matthews, personal communication). 
Related to this consideration is the idea that amino acids in 
the first and fourth positions may contribute to XPPXY spe- 
cificity. The fact that many of the sodium channels contain 
serines or alanines in the fourth position of the motif while all 
of the serine kinases contain phenylalanines or tyrosines, for 
example, indicates that perhaps ubtle differences in the shape 
of the motif lead to recognition of different WW domains. 
Future study of the specificity of WW domains will better 
illuminate this idea. 
The identification of the WW domain-binding sequence 
APPTPPPLPP in formins, proteins involved in mouse limb 
and kidney development [4], indicates the extent to which 
different WW domains may recognize different proline-rich 
ligands. Once more ligands to WW family proteins have 
been identified, the techniques of analysis used here can be 
applied to each new consensus, allowing for the prediction of 
more WW-XPPXY cognate complexes. It is interesting that 
the WW domain and the SH3 domain can compete in binding 
the proline-rich sequence in formins in vitro [4] (Fig. 5C). The 
proline-rich C-terminal region of the epithelial sodium chan- 
nel subunits, which contains the XPPXY motif, was originally 
characterized as an SH3-binding sequence, interacting with 
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spectrin [50,51]. Perhaps the proteins containing the WW do- 
main and proteins containing the SH3 domain can compete 
similarly in vivo in binding formins and the epithelial sodium 
channel. 
4. Concluding remarks 
The primary purpose of our theoretical study was to pro- 
vide guidelines for experiments o examine the molecular and 
biological function of the WW domain-ligand connection. The 
most direct experimental pproaches suggested by our data 
would be to mutate the XPPXY motifs in representative m m- 
bers of Gags, sodium channels, interleukin receptors, ~-dys- 
troglycan, and serine/threonine kinases and to assess the re- 
sulting phenotypes. Should new or expected (hypertension, 
immunodeficency, muscular dystrophy, or attenuation of viral 
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transformation) phenotypes be generated in transgenic ani- 
mals or in relevant cell culture models, detailed studies on 
the cognate WW domain-containing proteins could illuminate 
downstream signaling events of the investigated pathways. 
The three-dimensional structure of the WW domain of hu- 
man YAP in complex with its peptide ligand was recently 
solved using NMR spectroscopy [52]. Based on this data 
one could try to select by computer modeling the 'best fitting' 
pairs of ligate and ligand and then test them experimentally. 
Homology modeling of the WW domain may result in general 
'rules' for the structures of the XPPXY ligand. 
Study of the XPPXY motif and its structural nd functional 
relationship to the WW domain will therefore, no doubt, lead 
to an exponential increase in the understanding of a wide 
range of signaling processes and of the reasons for their mal- 
function in certain human diseases. Moreover considering 
Cl FORMIN + FBPs 
LIMB AND KIDNEY DEVELOPMENT 
FJ 
DYSTROGLYCAN + DYSTROPHIN 
DYSTROGLYCAN MUTATIONS 
° 'l 
1 it--- c 
DYSTROPHIN I~_~ N 
MUSCULAR DYSTROPHY MAP KINASE PATHWAY 
Fig. 5. Models of XPPXY-WW interaction. (A) The XPPXY motif and SH3 domain of viral Gag-Yes or Gag-Crk interact with the WW do- 
main and SH3 binding motif of vertebrate YAP, resulting in oncogenic transformation. I  normal cells the WW domain of YAP interacts with 
WBP-1 and/or WBP-2, which, when in free, unbound form, could be involved in positive control of cell growth. (B) Nedd4 or another elated 
WW family protein interacts at the membrane with the XPPXY motif of the epithelial sodium channel I]-subunit. Deletion of the XPPXY mo- 
tif or point mutation within the motif results in Liddle's syndrome. (C) A formin interacts with two formin binding proteins (FBP). The WW 
domain of one FBP and the SH3 domain of the other compete to bind to the proline-rich sequence TPPPL, resulting in the regulation of limb 
and kidney development. (D) An unknown WW family protein interacts with the XPPXY motif of the interleukin-2 receptor "/-chain at the 
membrane of a normal cell. Mutations of the extracellular o intracellular regions, which would cause deletion of the XPPXY motif, result in 
severe combined immunodeficiency. (E) MAP kinase phosphorylates a threonine (in the MAP kinase phosphorylation site PQTR) of MAP ki- 
nase activated protein kinase 2 (MAPKAP2), which leads to the interaction of the XPPXY motif of MAPKAP2 with the WW domain of 
Msbl. (F) One of the XPPXY motifs of dystroglycan i teracts with the WW domain of dystrophin, localizing dystrophin to the membrane of
a normal cell. Mutations resulting in deletion of the C-terminal region of dystrophin prevent this interaction, causing Duchenne muscular dys- 
trophy. C and N denote carboxy-and amino-termini, respectively, of dystrophin. In all models, the cell membrane is represented by a cross- 
hatched rectangle. 
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that both the WW domain and the core motif of its ligand are 
relatively short (38 and 5 residues), one could speculate that 
the human syndromes that involve mutations of these mod- 
ules could be treated successfully not only by gene therapy 
approaches, but also by low molecular weight compounds. 
Although peptides, even short ones composed of only 4 amino 
acids, are inefficient as drugs, the rigid molecular shapes re- 
presented by polyproline cores of the WW domain ligands 
could serve as guides for rational drug design or for choosing 
a repertoire of organic mimotopes for functional screens. 
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